Tarık Demir

647 total citations
41 papers, 333 citations indexed

About

Tarık Demir is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tarık Demir has authored 41 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tarık Demir's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Tarık Demir is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Tarık Demir collaborates with scholars based in Türkiye, United States and South Africa. Tarık Demir's co-authors include Ahmed O. Kaseb, Sunyoung S. Lee, Bılge Burçak Annagür, Fatih Kara, Mümtaz Yılmaz, Gülperi Çelik, Deniz Şelimen, Mesut Şeker, Hacı Mehmet Türk and Ahmet Bılıcı and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Medicine.

In The Last Decade

Tarık Demir

34 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarık Demir Türkiye 11 90 51 50 48 45 41 333
Murat Araz Türkiye 10 102 1.1× 29 0.6× 26 0.5× 76 1.6× 53 1.2× 62 341
C. Lawton United States 9 64 0.7× 106 2.1× 24 0.5× 38 0.8× 50 1.1× 21 592
Christina Theodore‐Oklota United States 10 106 1.2× 56 1.1× 37 0.7× 80 1.7× 35 0.8× 19 433
Sevcan Atay Türkiye 12 55 0.6× 25 0.5× 80 1.6× 42 0.9× 37 0.8× 36 363
Elena Castellano Italy 12 103 1.1× 42 0.8× 46 0.9× 30 0.6× 176 3.9× 39 524
Khushboo Sheth United States 9 25 0.3× 37 0.7× 41 0.8× 46 1.0× 21 0.5× 28 307
Mousumi Biswas United Kingdom 13 75 0.8× 34 0.7× 37 0.7× 102 2.1× 30 0.7× 33 420
Yan Hu China 13 79 0.9× 8 0.2× 50 1.0× 71 1.5× 55 1.2× 41 428
Damir Buković Croatia 14 127 1.4× 23 0.5× 51 1.0× 42 0.9× 120 2.7× 60 570
Farid Arman United States 10 40 0.4× 24 0.5× 50 1.0× 80 1.7× 34 0.8× 33 329

Countries citing papers authored by Tarık Demir

Since Specialization
Citations

This map shows the geographic impact of Tarık Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarık Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarık Demir more than expected).

Fields of papers citing papers by Tarık Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarık Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarık Demir. The network helps show where Tarık Demir may publish in the future.

Co-authorship network of co-authors of Tarık Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Tarık Demir. A scholar is included among the top collaborators of Tarık Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarık Demir. Tarık Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Katherine J., Betül Gök Yavuz, Tarık Demir, et al.. (2025). Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma. npj Precision Oncology. 9(1). 60–60. 2 indexed citations
2.
3.
Demir, Tarık, et al.. (2024). Double lung transplantation in patients with recent history of malignancy.. Journal of Clinical Oncology. 42(16_suppl). e20614–e20614.
4.
5.
Demir, Tarık, Murat Araz, Mehmet Zahid Koçak, et al.. (2024). Efficacy of systemic treatments in patients with metastatic lung invasive mucinous adenocarcinoma.. Journal of Clinical Oncology. 42(16_suppl). e20609–e20609.
6.
Demir, Tarık, et al.. (2024). Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers. Critical Reviews in Oncology/Hematology. 199. 104388–104388. 3 indexed citations
7.
Yang, Hee Chul, Tarık Demir, Anjana V. Yeldandi, et al.. (2024). Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancer. American Journal of Transplantation. 25(1). 209–214.
8.
Demir, Tarık, et al.. (2022). Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon Cancer Patients. Journal of College of Physicians And Surgeons Pakistan. 32(2). 186–192. 2 indexed citations
9.
Demir, Tarık, et al.. (2022). Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging. Radiology and Oncology. 56(2). 150–155. 2 indexed citations
10.
Demir, Tarık, et al.. (2021). Primitive Neuroectodermal Tumor of the Testis. Journal of College of Physicians And Surgeons Pakistan. 31(11). 1362–1365.
11.
Türk, Hacı Mehmet, et al.. (2021). Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme. Journal of College of Physicians And Surgeons Pakistan. 31(1). 39–44. 5 indexed citations
12.
Demir, Tarık, Sunyoung S. Lee, & Ahmed O. Kaseb. (2021). Systemic therapy of liver cancer. Advances in cancer research. 149. 257–294. 64 indexed citations
13.
Türk, Hacı Mehmet, et al.. (2020). Clinicopathological Features of Gastroenteropancreatic Neuroendocrine Neoplasms. Journal of College of Physicians And Surgeons Pakistan. 30(8). 863–867. 2 indexed citations
14.
Demir, Tarık, Murat Araz, Osman Köstek, et al.. (2020). Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?. Current Problems in Cancer. 45(1). 100619–100619. 4 indexed citations
15.
Türk, Hacı Mehmet, et al.. (2019). Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Current Problems in Cancer. 44(1). 100497–100497. 3 indexed citations
16.
Şeker, Mesut, Ahmet Bılıcı, Huri Bulut, et al.. (2018). Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Oncology Research and Treatment. 41(9). 545–549. 4 indexed citations
17.
Demir, Tarık, et al.. (2016). Anthropometric measurements may be informative for nursing home-acquired pneumonia. Pakistan Journal of Medical Sciences. 32(3). 694–9. 13 indexed citations
18.
Demir, Tarık, et al.. (2016). The role of geriatric assessment tests and anthropometric measurements in identifying the risk of falls in elderly nursing home residents. Saudi Medical Journal. 37(10). 1101–1108. 6 indexed citations
19.
Demır, Kenan, et al.. (2014). Fragmented QRS in patients with systemic lupus erythematosus. Scandinavian Cardiovascular Journal. 48(4). 197–201. 8 indexed citations
20.
Çelik, Gülperi, Bılge Burçak Annagür, Mümtaz Yılmaz, Tarık Demir, & Fatih Kara. (2012). Are sleep and life quality of family caregivers affected as much as those of hemodialysis patients?. General Hospital Psychiatry. 34(5). 518–524. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murat Araz Breakdown of academic impact, for papers by C. Lawton Breakdown of academic impact, for papers by Christina Theodore‐Oklota Breakdown of academic impact, for papers by Sevcan Atay Breakdown of academic impact, for papers by Elena Castellano Breakdown of academic impact, for papers by Khushboo Sheth Breakdown of academic impact, for papers by Mousumi Biswas Breakdown of academic impact, for papers by Yan Hu Breakdown of academic impact, for papers by Damir Buković Breakdown of academic impact, for papers by Farid Arman
Rankless by CCL
2026